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Classically, neoplasia has been considered to be primarily a distur-
bance in the regulation of proliferation, or at least deregulation has
been proposed to be essential for cancer development (Hartwell
and Kastan, 1994). It is, therefore, not surprising that a high prolif-
erative activity is usually correlated with a more aggressive 
behaviour and a poorer prognosis in many malignancies. In some
malignancies, tumour cell proliferation has been reported to be a
strong independent prognostic factor, e.g. in breast cancer, bladder
cancer and malignant lymphomas (Porter-Jordan and Lippman,
1994; Mulder et al, 1992; Hall et al, 1988).
In colorectal cancer, however, the associations between tumour
cell proliferation and prognosis are more difficult to interpret.
Conflicting results have been reported and the differences between
reports are most probably independent of the choice of prolifera-
tion marker. S-phase fraction, proliferative cell nuclear antigen
(PCNA), Ki-67 and bromo- or iododeoxyuridine (BrdUrd/IdUrd)
have all been regarded as prognostic indicators in colorectal
cancer. Although some reports suggest a correlation between rapid
tumour cell proliferation and poor prognosis (Witzig et al, 1991;
Pietra et al, 1996), most reports find no support for proliferation as
a prognostic factor (Kubota et al, 1992; Al-Sheneber et al, 1993;
Rew, 1993; Zarbo et al, 1997), and some indicate a better prog-
nosis for rapidly proliferating colorectal cancer (Neoptolemos et
al, 1995; Paradiso et al, 1996). These results have been very
confusing and have given rise to discussions and studies of strictly
technical topics (Bauer et al, 1993).
Colorectal cancers are known to be heterogeneous with respect to
several parameters, including tumour cell proliferation (Jass et al,
1986; Shepherd et al, 1988; Koha et al, 1990; Lindmark et al, 1991),
and such heterogeneity could partly explain the conflicting results.
Systematic heterogeneity was found in human colorectal cancers
after in vivo incorporation of IdUrd, with the luminal border
showing a higher proliferation than the invasive margin (Palmqvist
et al, 1998). In addition, we reported a correlation between slowly
proliferating tumours (low fraction of proliferative cells and/or long
potential doubling time) and a poor prognosis. This correlation was
observed for both the luminal border and the invasive margin. Our
results suggested that one must control for heterogeneity when
measuring the proliferative activity within colorectal cancers, and
that sampling from defined compartments is desirable.
The biological explanation for the systematic heterogeneity is
not known. Several faecal factors, such as secondary bile acids and
short chain fatty acids, are known to have an effect on proliferation
in colonic cells (Mullan et al, 1990; Butler et al, 1992), and there-
fore these factors could be responsible for the systematic differ-
ences between separate compartments in colorectal cancer. If this
hypothesis is correct, the proliferative activity is expected to
decrease as the diffusion distance for faecal factors increases.
The aims of this study were to investigate the prognostic impact
of tumour cell proliferation using an endogenous marker for cell
proliferation, when the systematic heterogeneity within the
colorectal cancers was taken into consideration. We also evaluated
whether the proliferative activity at the invasive margin was
dependent on the depth of invasion in the bowel wall and on other 
clinicopathological parameters.
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Summary The conflicting results about the prognostic impact of tumour cell proliferation in colorectal cancer might be explained by the
heterogeneity observed within these tumours. We have investigated whether a systematic spatial heterogeneity exists between different
compartments, and whether the presence of such a systematic heterogeneity has any impact on survival. Fifty-six Dukes’ stage B colorectal
cancers were carefully morphometrically quantified with respect to the immunohistochemical expression of the proliferative marker Ki-67 at
both the luminal border and the invasive margin. The proliferative activity was significantly higher at the luminal border compared with the
invasive margin (P < 0.001), although the two compartments were also significantly correlated with each other. Tumours with low proliferation
at the invasive margin had a significantly poorer prognosis both in univariate (P = 0.014) and in multivariate survival analyses (P = 0.042). We
conclude that Dukes’ B colorectal cancers exhibit a systematic spatial heterogeneity with respect to proliferation, and tumours with low
proliferation at the invasive margin had a poor prognosis. The present data independently confirm recent results from the authors, and provide
new insights into the understanding of tumour cell proliferation in colorectal cancer.
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Patients
Fifty-six patients with Dukes￿ stage B colorectal cancer (Dukes,
1932), who underwent surgery at the University Hospital of Ume￿,
were included in this retrospective study. The patients had undergone
surgery during the period 1987—92. Out of the 56 colorectal cancer
patients, 47 did not receive adjuvant chemotherapy, and underwent
potential curative surgery treatment and were regarded as cured if
both the surgeon (￿￿) and the pathologist (RS) believed that all
tumour tissue had been removed. Only these 47 patients were
included in the survival analyses. Out of the 56 patients, 31 (55%)
were men and 25 (45%) were women. Seventeen tumours (30%)
were located in the right colon (defined as caecum, colon ascendens
and colon transversum), 24 (43%) in the left colon (colon descendens
and colon sigmoideum) and 15 (27%) in the rectum. The median age
of the patients was 72.0 (range 39—89), with five patients younger
than 60 years of age, 17 between 60 and 69 years, 21 between 70 and
79 years, and 13 patients 80 years of age or older. The follow-up time
of the surviving patients ranged from 46 to 106 months (median
67.0). To verify the accuracy of corrected survival used in this study,
curves of corrected survival for the entire material were compared
with relative survival data, i.e. death rates of the colorectal cancer
group compared with death rates of a corresponding normal popula-
tion. These two survival curves showed good agreement.
Histology
Each colorectal cancer was classified by the pathologist (RS)
according to grade (high, low), growth pattern at the invasive
margin (pushing or infiltrating), the degree of lymphocytic infiltra-
tion at the invasive margin (low or high), tumour type (mucinous or
not mucinous) and the presence of vascular invasion (yes or no). In
addition, the maximum depth of tumour invasion observed (in four
sections) for each tumour was measured with a millimetre ruler.
Immunohistochemical procedures
Each tumour was systematically sampled by dividing the tumour
into two central and two peripheral regions. From each region, a
tumour sample cut perpendicular to the mucosal surface was
collected and fixed overnight in phosphate-buffered neutral 10%
formalin and subsequently embedded in paraffin. A 4-mm thick
section was cut from each paraffin block, including the entire
tumour, i.e. from the intestinal lumen all the way to the submu-
cosa, muscular layer or to the peripheral fat. The sections (four
from each tumour) were left to dry overnight in 37°C, followed the
next morning by 30 min in 56°C. After dewaxing and rehydration,
the slides were microwaved (750 W) in citrate buffer (pH 6.0) for
4  ´ 5 min, followed by a staining procedure in an automated
immunostainer (Ventana ES, Ventana, Tucson, AZ, USA) to
obtain the most constant conditions (Grogan, 1992; Nichols et al,
1996). A monoclonal Ki-67 antibody (A0047, Dako, Denmark)
was used at a dilution of 1:75, followed by antibody visualization
according to the Ventana-program. Subsequently, the slides were
manually counterstained with Mayer￿s haematoxylin for 1.5 min.
The Ventana ES is constrained to perform all incubations at 40°C
slide reaction temperature. From each tissue block, adjacent
samples were also taken for routine histological evaluations. In all
daily staining procedures, tissue samples from normal colon
epithelium were included as a positive control.
Morphometrical analysis
The methods used have recently been described in detail by
Palmqvist et al (1998). Briefly, one immunohistochemically
stained section from each of the four tissue samples (collected as
described above) was used for morphometrical analysis. A Zeiss
microscope (40 ´ objective magnification) equipped with an
eyepiece squared graticule was used to define the proper size of
the counting frame in each of the tumours (Gundersen et al, 1988).
From each tumour, counting frames from about 40 fields of vision
were measured in a systematic random fashion, i.e. the first field
was selected at random whereas subsequent fields were sampled
systematically by adjusting the distance between individual fields
of vision so that they were roughly proportional to the overall area
in question. Two tumour compartments were evaluated in each
colorectal cancer section. One was represented by the most super-
ficial fourth (corresponding to the luminal tumour part), whereas
the other was represented by the deepest fourth (corresponding to
the invasive margin). The two tumour compartments were
analysed separately without knowledge of the results from earlier
morphometrical evaluation.
Two different unbiased counting frames were used for counting
nuclei, i.e. one for positive and the other for negative nuclei
(Gundersen, 1977). In each field of vision, both the number of
positive and negative nuclei were counted in each of the defined
counting frames, respectively, and subsequently the two-dimen-
sional numerical density was calculated for both positive and
negative nuclei. The labelling index (LI) was calculated as the
two-dimensional numerical density for positive nuclei divided by
the total two-dimensional numerical density for both positive and
negative nuclei.
To investigate the variability of the morphometrical measure-
ments, we performed repetitive measurements of LI, as described
above, in four randomly chosen tumours. The coefficient of error
(CE) for differences between paired measurements at the luminal
border was 0.059 for intraobserver variability and 0.087 for inter-
observer variability. Regarding the measurements at the invasive
margin, the CE was 0.049 for intraobserver variability and 0.085
for interobserver variability.
Statistics
Spearmann￿s correlation coefficient (rho) and Wilcoxon matched-
pairs signed-ranks test were used to compare sets of continuous
parameters measured on the same tumour. Differences between
groups were examined using the Kruskal—Wallis test. In a univariate
survival analysis, Kaplan—Meier￿s method was used to estimate
corrected survival, and comparison between groups was performed
with the log-rank test. Corrected survival analyses measure the
proportion of deaths resulting from cancer. The time measured from
operation to death is recorded as the survival time, in which death
with known locoregional or distant metastases was processed as an
event. If no event occurred, the patient was censored at the time of
last clinical follow up or death from other causes.
To evaluate the simultaneous effect of different factors on
survival, the Cox proportional hazard model was used. The
hypothesis that the coefficients of each variable were equal to 0
was tested using the global chi-squared test. A P-value less than
0.05 was required for statistical significance and two-sided tests
were performed for all analyses. Statistical analyses were
performed using SPSS version 7.5 (SPSS, IL, USA).
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Among the 56 colorectal cancers, we found a mean value of 43.7%
for Ki-67 LI at the luminal border compared with 36.8% at the
invasive margin. The latter value was significantly lower in a
paired test (P < 0.001). In only ten cases was LI higher at the inva-
sive margin compared with the luminal border. Nevertheless, LI at
the luminal border and the invasive margin were correlated (rho =
0.829; P < 0.001). In contrast, LI at the invasive margin was not
correlated with the infiltrative depth of the tumour within the
bowel wall (rho = —0.032; P = 0.814).
There was no difference in proliferative activity in relation to
tumour site (P = 0.969). The mean values from the luminal border
in different sites were 40.3 ± 3.2 (s.e.m.) (range 20.3—66.8), 
45.9  ± 3.6 (13.2—77.6) and 43.9 ± 3.3 (21.9—69.4) for right colonic,
left colonic and rectal tumours respectively. For measurements at
the invasive margin, the mean values were 37.1 ± 3.0 (19.1—58.9),
36.8 ± 2.9 (12.7—63.6) and 36.6 ± 3.0 (15.3—57.1) respectively.
Out of the 47 patients included in the survival analyses, 29.8%
died from their cancer disease, whereas 70.2% was censored.
Using the lowest quartile as a cut-off level (LI = 27.4%) in a
univariate analysis, a significantly poorer survival (P = 0.0139)
was detected for patients with low LI at the invasive margin
(Figure 1). In contrast, no such impact on survival was recorded
for LI at the luminal border (P = 0.705). If, instead, median values
were used as cut-off levels, low LIs at both luminal border and
invasive margin were significantly associated with poorer prog-
nosis (P = 0.0167 and P = 0.0439 respectively).
The clinicopathological parameters age, gender, grade, vascular
invasion, growth pattern at invasive margin, tumour type, depth of
tumour invasion, degree of lymphocytic infiltration and LI at the
invasive margin were put into a multiple Cox regression model for
a better estimation of the prognostic significance of these vari-
ables. The global chi-squared test was significant (P = 0.0072)
indicating that our model was adequate, but one should neverthe-
less be aware of the small number of events in the present study
and the consequently poor statistical power. Only LI at the inva-
sive margin, dichotomized using the lowest quartile as the cut-off
level, turned out to be a significant prognostic marker (relative risk 
(RR) = 12.1; P = 0.042). Although not statistically significant, a
borderline value was observed for the growth pattern at the inva-
sive margin (RR = 4.41; P = 0.062; Table 1).
DISCUSSION
Although the approach used in the present study is similar to that
of our recent study (Palmqvist et al, 1998), it differs both with
respect to the proliferation marker and the patient material studied.
This was carried out to reduce the random risk of investigating a
non-representative population. We retrospectively collected a
group of Dukes￿ stage B colorectal cancers, which most probably
have the greatest benefit by an improvement of prognostic tools.
We have used a well-established morphometrical method to
measure the immunohistochemical outcome of Ki-67 (Weibel,
1979; Gundersen, 1986; Gundersen et al, 1988). Only one excep-
tion from the theoretically most desirable design was made, i.e. in
the first sampling step we have used a strictly systematic sampling
in contrast to a sampling scheme with a random start followed by a
systematic sampling. This systematic procedure was chosen
because it is more feasible in clinical practice, and we have
recently shown that it causes only a minor sampling error
(Palmqvist et al, 1998). When analysing the luminal border and the
invasive margin, a strict definition was used, i.e. the most superfi-
cial and deepest fourth of the tumour depth was evaluated respec-
tively. This definition was chosen for both simplicity and
reproducibility.
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Table 1 Results of Cox proportional hazard model in 47 colorectal Dukes, B
cancers
Variable Relative 95% P-value
risk (eb) Confidence
interval
Gender
Man 1.00
Woman 0.37 0.06–2.11 0.26
Agea 1.06 0.96–1.18 0.21
Tumour type
Mucinous 1.00
Not mucinous 0.47 0.05–4.27 0.50
Growth pattern
Pushing 1.00
Infiltrating 4.41 0.93–21.00 0.062
Vascular invasion
Present 1.00
Absent 1.61 0.30–8.47 0.58
Grade
High 1.00
Low 1.21 0.28–5.19 0.80
Lymphocytic reaction
Low 1.00
High 0.62 0.15–2.58 0.51
Depth of invasiona 1.14 0.92–1.41 0.25
Ki-67 luminal border
Above lowest quartile 1.00
Lowest quartile 0.22 0.03–1.81 0.16
Ki-67 invasive margin
Above lowest quartile 1.00
Lowest quartile 12.11 1.10–133 0.042
aContinuous variables.
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Figure 1 Kaplan–Meier surviving curve showing impaired survival for
patients with low (lowest quartile used as cut-off level) Ki-67 labelling indices
(LIs)In the present study, the proliferative activity was found to be
systematically higher at the luminal border compared with the
invasive margin in colorectal cancers. Quirke et al (1985) consid-
ered the idea of systematic heterogeneity already in 1985, but did
not detect a significant difference between superficial and deep
compartments in colorectal cancers. This was probably due to the
use of flow cytometry instead of immunohistochemistry. With
flow cytometry, it is difficult both to define separate tumour
compartments and to avoid contamination of the samples with
non-tumour cells, but these problems are, however, technically
possible to solve using microdissection and cytokeratin-based
gating. Our data are supported by reports after in vitro labelling
with BrdUrd (Taniyama et al, 1993) and by the distributions of Ki-
67-positive tumour and endothelial cells (Vermeulen et al, 1995) in
colorectal cancers. Furthermore, the same proliferative pattern as
described in this study has recently been shown in gastric carci-
nomas (Ramires et al, 1997). The striking systematic hetero-
geneity with higher proliferative activity at the luminal border
compared with the invasive margin emphasize the importance of
measuring well-defined tumour areas when evaluating parameters
associated with proliferation in polarized tumours such as
colorectal cancer.
Factors such as secondary bile acids (mainly lithocholic acids),
other steroid-derived compounds, short-chain fatty acids and the
direct influence from the bacterial content are known to affect the
proliferation of colorectal cells (Mullan et al, 1990). However, we
found no correlation between the depth of tumour invasion and the
proliferative activity at the invasive margin. This result is not
consistent with the hypothesis that increased proliferation of the
cells at the luminal border is induced by the luminal content. If this
were true, proliferation rates should decrease as the distance from
the luminal contents increases. Other luminal occurrences can, of
course, be involved, e.g. the preoperative colon-cleaning prepara-
tions, such as laxatives and enemas, have been shown to induce an
increased mucosal proliferative activity (Lehy et al, 1984). Not
only these luminal occurrences but also local non-specific regener-
ative factors from the ulcerative process at the luminal border may
increase the proliferation in this compartment.
The significant association between low tumour cell prolifera-
tion at the invasive margin and poor prognosis in Dukes￿ B
colorectal cancer, which were recorded in both uni- and multi-
variate analyses, provides new insights about the influence of
tumour cell proliferation on biological behaviour, and might also
separate colorectal cancer from other types of cancers, e.g. breast
cancers and malignant lymphomas. Nevertheless, there are reports
which, directly or indirectly, support this new view of the relation
between proliferation and prognosis in colorectal cancer. From
two studies on the invasive margin in colorectal cancer, Taniyama
et al (1993, 1996) report that low tumour cell proliferative activity
is correlated with areas of low differentiation, and that decreased
proliferation in diploid tumours is correlated with increased
numbers of lymph node metastases. Another circumstantial
support is that the proliferation rate decreases when the colorectal
cancer stage increases (Kubota et al, 1992; Roncucci et al, 1992).
Furthermore, low PCNA indices in a group of patients with
advanced colorectal cancers given chemotherapy have been shown
to be correlated with a poorer prognosis (Paradiso et al, 1996).
There are, however, other results, mainly from flow cytometrical
studies of S-phase fraction, indicating a better prognosis for
patients with low tumour cell proliferation (Harlow et al, 1991;
Witzig et al, 1991).
The present study does not separate tumour from colon and
rectum and considers only Dukes￿ stage B colorectal cancers.
Speculatively, if low proliferative activity at the invasive margin
merely is a secondary phenomenon to the metastasizing process
and, therefore, mainly would be a measurement of the likelihood
of having metastases, it would not be surprising to find patients
with highly proliferative tumours and already established distant
spread (Dukes￿ D) to have a very poor prognosis. Furthermore, the
relation between proliferation and apoptosis is another interesting
track when trying to understand why patients with tumours
showing high proliferative activity have a favourable outcome.
Tumour cells with high proliferative activity might be those
having an imbalance in ￿proapoptotic￿ and ￿antiapoptotic￿ signals
making them more vulnerable to apoptotic death, whereas tumour
cells with low proliferation might be those being more in balance
and therefore will survive (Evan, 1997). Further studies are needed
to clarify the role of the proliferative activity in other Dukes￿
stages and in relation to apoptosis and topography.
To summarize, we conclude that the proliferative activity is
higher at the luminal border compared with the invasive margin in
the main part of colorectal cancers and, moreover, that a low prolif-
erative activity is correlated with a poorer prognosis in Dukes￿ B
colorectal cancer. This new insight into tumour cell proliferation
might have impact on future treatment of colorectal cancer.
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